BioAtla, Inc. (BCAB)
4.66
-0.99
(-17.52%)
USD |
NASDAQ |
Apr 07, 16:00
4.86
+0.20
(+4.29%)
Pre-Market: 09:00
BioAtla Price : 4.66 for April 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 3.39 |
| Actinium Pharmaceuticals, Inc. | 1.17 |
| Aldeyra Therapeutics, Inc. | 1.52 |
| Annovis Bio, Inc. | 2.27 |
| Azitra, Inc. | 0.239 |
Price Related Metrics
| PS Ratio | 35.99 |
| PEG Ratio | -0.0009 |
| Earnings Yield | -812.5% |
| Market Cap | 7.721M |
| PEGY Ratio | -0.0009 |